Regulatory T Cell Heterogeneity in the Steady State and Tumor

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• Regulatory T cells (Tregs) are crucial for immune homeostasis and preventing autoimmunity.
• Tregs display heterogeneity driven by developmental, cytokine-dependent, and tissue-specific programs in steady states.
• In tumors, Tregs differentiate further, acquiring specialized suppressive functions within the tumor microenvironment.

Purpose of the Study:

• To review the heterogeneity of regulatory T cells (Tregs) in both healthy and tumor contexts.
• To integrate current knowledge on Treg differentiation, tissue adaptation, and tumor-specific responses.
• To discuss therapeutic strategies targeting tumor-resident Tregs while preserving systemic immune tolerance.

Main Methods:

• Literature review integrating developmental pathways.
• Analysis of tissue residency programs.
• Examination of transcriptional profiling data.
• Assessment of tumor-specific Treg adaptation.

Main Results:

• Treg heterogeneity is substantial across tissues in the steady state.
• Tregs differentiate uniquely within the tumor microenvironment due to chronic stimulation and local cues.
• Tumor-infiltrating Tregs possess specialized suppressive functions.

Conclusions:

• Treg heterogeneity is a fundamental aspect of immune regulation in both health and disease.
• Understanding Treg diversity is critical for developing effective cancer immunotherapies.
• Targeting tumor-resident Tregs offers a promising strategy for cancer treatment with potential to spare systemic immune tolerance.